Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3 -Mutated AML
Author(s) -
Roby P. Bhattacharyya,
William P. Hanage,
T Harvard
Publication year - 2022
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmx220003
Subject(s) - medicine , refractory (planetary science) , chemotherapy , oncology , cancer research , astrobiology , physics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom